EMA 2024 Report Highlights: Innovations in Medi...

By João L. Carapinha

June 17, 2025

The EMA 2024 report highlights the European Medicines Agency’s (EMA) achievements, challenges, and forward strategy across human and veterinary medicines regulation. The report documents a year of substantial progress. It emphasizes accelerated di...
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Elsa – FDA AI Tool: Navigating Efficiency and Ethics
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
Quantifying EU Medicine Access Challenges
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
EU Patent Licensing Framework: Enhancing Crisis Management in the EU
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030